CMS to analyze coverage of monoclonal antibody Alzheimer's drug
The U.S. Centers for Medicare and Medicaid Services (CMS) will conduct a nationa...Read more on AuntMinnie.comRelated Reading:
fMRI shows dementia patients' brain response to music
New Alzheimer's definition relies on imaging biomarkers
DTI-MRI ties lack of fitness to cognitive decline
Flortaucipir-PET could lead in early Alzheimer's detection
ACR revises Appropriateness Criteria
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Alzheimer's | Brain | Centers for Medicare and Medicaid Services (CMS) | Dementia | Medicaid | Medicare | Neurology | Radiology